Germany approves third trial of COVID-19 vaccine candidate
Unlisted biotech firm IDT Biologika has won approval from Germany's vaccine regulator to become the third German company after BioNTech and CureVac to launch human trials of an experimental coronavirus vaccine in the country. The trial of the vaccine, which has been developed with the German Centre

Full story is loading. Click here if it doesn't...